Repare Therapeutics Inc. (RPTX)
USD 1.43
(1.42%)
USD 1.43
(1.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 51.13 Million | 131.83 Million | 7.6 Million | 135 Thousand | - | - |
| Cost of Revenue | 131.2 Million | 4.18 Million | 3.34 Million | 1.78 Million | 968 Thousand | 407 Thousand |
| Gross Profit | -80.07 Million | 127.64 Million | 4.25 Million | -1.65 Million | -968 Thousand | -407 Thousand |
| Operating Expenses | 167.35 Million | 151.62 Million | 116.26 Million | 54.43 Million | 26.37 Million | 12.82 Million |
| Selling, General and Administrative Expenses | 33.76 Million | 32.56 Million | 26.21 Million | 14.34 Million | 5.38 Million | 2.91 Million |
| Research and Development Expenses | 133.59 Million | 119.06 Million | 90.04 Million | 40.09 Million | 20.99 Million | 9.9 Million |
| Other Expenses | - | -43 Thousand | -41 Thousand | -16 Thousand | -1.35 Million | -1.13 Million |
| Cost and Expenses | 167.35 Million | 151.62 Million | 116.26 Million | 54.43 Million | 26.37 Million | 12.82 Million |
| Operating Income | -116.22 Million | -19.79 Million | -108.66 Million | -54.3 Million | -26.37 Million | -12.82 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -9.38 Million | 15.14 Million | -1.67 Million | -1.32 Million | 195 Thousand | 35 Thousand |
| Earnings before Tax | -103.17 Million | -13.9 Million | -108.58 Million | -54.74 Million | -27.02 Million | -14.24 Million |
| Net Income | -93.79 Million | -29.04 Million | -106.9 Million | -53.41 Million | -27.21 Million | -14.28 Million |
| Earnings Per Share Basic | -2.23 | -0.69 | -2.83 | -1.45 | -0.74 | -0.90 |
| Earnings Per Share Diluted | -2.23 | -0.69 | -2.83 | -1.45 | -0.74 | -0.90 |
| Weighted Average Shares Outstanding | 42.09 Million | 41.92 Million | 37.81 Million | 36.9 Million | 36.66 Million | 15.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.09 Million | 41.92 Million | 37.81 Million | 36.9 Million | 36.66 Million | 15.79 Million |
| Gross Margin | -1.57 | 0.97 | 0.56 | -12.24 | - | - |
| EBIT Margin | -2.23 | -0.15 | -14.28 | -397.32 | - | - |
| Profit Margin | -1.83 | -0.22 | -14.07 | -395.68 | - | - |
| EBITDA | -114.27 Million | -17.81 Million | -107.18 Million | -53.4 Million | -25.48 Million | -13.51 Million |
| Earnings Before Tax Margin | -2.27 | -0.15 | -14.30 | -402.24 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.07 Million | 52.4 Million | 51.13 Million | 13.04 Million | 2.15 Million | 30.24 Million |
| Cost of Revenue | 488 Thousand | 501 Thousand | 1.95 Million | 506 Thousand | 1.04 Million | 1.05 Million |
| Gross Profit | 585 Thousand | 51.9 Million | 49.18 Million | 12.54 Million | 1.11 Million | 29.19 Million |
| Operating Expenses | 37.64 Million | 41.08 Million | 163.94 Million | 42.99 Million | 40.57 Million | 42.5 Million |
| Selling, General and Administrative Expenses | 8.31 Million | 8.61 Million | - | 8.53 Million | 7.86 Million | 8.71 Million |
| Research and Development Expenses | 29.32 Million | 32.46 Million | - | 34.46 Million | 32.7 Million | 33.78 Million |
| Other Expenses | -29 Thousand | -24 Thousand | -119 Thousand | -46 Thousand | -32 Thousand | -26 Thousand |
| Cost and Expenses | 38.13 Million | 41.58 Million | 165.89 Million | 43.49 Million | 40.57 Million | 42.5 Million |
| Operating Income | -37.05 Million | 10.81 Million | -114.76 Million | -30.45 Million | -38.41 Million | -12.25 Million |
| Interest Expense | - | - | - | 3.74 Million | - | - |
| Income Tax Expense | 586 Thousand | 629 Thousand | -7.91 Million | 606 Thousand | -16.29 Million | 3.11 Million |
| Earnings before Tax | -34.18 Million | 13.79 Million | -101.71 Million | -27.42 Million | -35.17 Million | -8.83 Million |
| Net Income | -34.77 Million | 13.16 Million | -93.79 Million | -28.03 Million | -18.87 Million | -11.94 Million |
| Earnings Per Share Basic | -0.82 | 0.31 | - | -0.67 | -0.45 | -0.28 |
| Earnings Per Share Diluted | -0.82 | 0.30 | - | -0.67 | -0.45 | -0.28 |
| Weighted Average Shares Outstanding | 42.44 Million | 42.23 Million | 42.09 Million | 42.13 Million | 42.1 Million | 42.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.44 Million | 44.02 Million | 42.09 Million | 42.13 Million | 42.1 Million | 42.08 Million |
| Gross Margin | 0.55 | 0.99 | 0.96 | 0.96 | 0.51 | 0.97 |
| EBIT Margin | -34.08 | 0.22 | - | -2.30 | -17.78 | -0.39 |
| Profit Margin | -32.41 | 0.25 | -1.83 | -2.15 | -8.74 | -0.39 |
| EBITDA | -36.57 Million | 11.31 Million | - | -29.94 Million | -38.37 Million | -11.71 Million |
| Earnings Before Tax Margin | -34.54 | 0.21 | -2.24 | -2.33 | -17.79 | -0.41 |
BAYN
IMP
BSEN
MARALOVER
TESI
LV1